Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Pyxis Oncology (PYXS) Leases (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Leases for 2 consecutive years, with $11.4 million as the latest value for Q4 2025.

  • Quarterly Leases fell 6.73% to $11.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.4 million through Dec 2025, down 6.73% year-over-year, with the annual reading at $11.4 million for FY2025, 6.73% down from the prior year.
  • Leases for Q4 2025 was $11.4 million at Pyxis Oncology, down from $11.6 million in the prior quarter.
  • The five-year high for Leases was $12.8 million in Q1 2024, with the low at $11.4 million in Q4 2025.